Clinical Trial Update: A Phase Ⅳ Study of Decitabine in Myelodysplastic Syndrome [Phase 4]

View source ↗

Summary

This clinical trial update discusses a Phase 4 study of decitabine in myelodysplastic syndromes, with the trial status currently UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes

Drugs mentioned

• Decitabine (Decitabine)

Snippet

Sponsor: Cttq | Conditions: Myelodysplastic Syndrome | Phase 4 | Status: UNKNOWN